Detalles de la búsqueda
1.
Mucopolysaccharidosis type VII (Sly syndrome) - What do we know?
Mol Genet Metab;
141(3): 108145, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38301529
2.
Major clinical events and healthcare resource use among patients with long-chain fatty acid oxidation disorders in the United States: Results from LC-FAOD Odyssey program.
Mol Genet Metab;
142(1): 108350, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38458123
3.
Response to triheptanoin therapy in critically ill patients with LC-FAOD: Report of patients treated through an expanded access program.
Mol Genet Metab;
136(2): 152-162, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35459555
4.
Long-term efficacy and safety of vestronidase alfa enzyme replacement therapy in pediatric subjects < 5 years with mucopolysaccharidosis VII.
Mol Genet Metab;
136(1): 28-37, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331634
5.
Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders.
Genet Med;
23(5): 816-829, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33495527
6.
Urinary glycosaminoglycans as a potential biomarker for evaluating treatment efficacy in subjects with mucopolysaccharidoses.
Mol Genet Metab;
130(1): 7-15, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32224020
7.
Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses.
Mol Genet Metab;
130(4): 255-261, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32563631
8.
The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII.
Mol Genet Metab;
129(3): 219-227, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32063397
9.
Results from a 78-week, single-arm, open-label phase 2 study to evaluate UX007 in pediatric and adult patients with severe long-chain fatty acid oxidation disorders (LC-FAOD).
J Inherit Metab Dis;
42(1): 169-177, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30740733
10.
Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
Mol Genet Metab;
116(1-2): 53-60, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26116311
11.
Corrigendum to "The long-term safety and efficacy of vestronidase alfa, rhGUS enzyme replacement therapy, in subjects with mucopolysaccharidosis VII" [Mol Genet Metab 2020 Mar;129(3):219-227].
Mol Genet Metab;
131(1-2): 285, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32843286
12.
Disease characteristics, effectiveness, and safety of vestronidase alfa for the treatment of patients with mucopolysaccharidosis VII in a novel, longitudinal, multicenter disease monitoring program.
Orphanet J Rare Dis;
19(1): 189, 2024 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38715031
13.
Growth patterns in patients with mucopolysaccharidosis VII.
Mol Genet Metab Rep;
36: 100987, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37415957
14.
Estimating the Prevalence of Rare Diseases: Long-Chain Fatty Acid Oxidation Disorders as an Illustrative Example.
Adv Ther;
39(7): 3361-3377, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35674971
15.
Newborn Screening for Lysosomal Storage Disorders: Quo Vadis?
Clin Chem;
62(11): 1430-1438, 2016 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27630153
16.
Newborn screening of lysosomal storage disorders.
Clin Chem;
56(7): 1071-9, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20489136
17.
The re-occurrence of cardiomyopathy in propionic acidemia after liver transplantation.
JIMD Rep;
54(1): 3-8, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32685343
18.
Newborn screening.
Crit Rev Clin Lab Sci;
46(2): 55-82, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19255915
19.
Commentary on a Delphi clinical practice protocol for the diagnosis and management of very long chain acyl-CoA dehydrogenase deficiency by Arnold et al.
Mol Genet Metab;
96(3): 81-2, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19081279
20.
Regulatory strategies for rare diseases under current global regulatory statutes: a discussion with stakeholders.
Orphanet J Rare Dis;
14(1): 36, 2019 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30736861